missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies AKT Inhibitor VIII
PI3K/AKT pathway inhibitor; Inhibits AKT1, AKT2, and AKT3
£193.05 - £558.90
Specifications
CAS | 612847-09-3 |
---|---|
Synonym | AKTi-1/2; AKT 1/2 inhibitor |
Molecular Formula | C34H29N7O |
Purity | ≥98% |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
17110152
|
STEMCELL Technologies
72942 |
1 mg |
£193.05
1mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
17120152
|
STEMCELL Technologies
72944 |
10 mg |
£558.90
10mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
- AKT Inhibitor VIII is a cell-permeable, allosteric inhibitor of all three forms of the kinase AKT (AKT1, AKT2, and AKT3) with IC50 values of 58, 210, and 2,200 nM, respectively (Lindsley et al.; Calleja et al.) It displays good selectivity against a panel of 70 other kinases with micromolar inhibition against some kinases, such as calcium/calmodulin-dependent protein kinase 1 and smooth muscle myosin light-chain kinase (Logie et al.)
- Sensitizes prostate tumor and cervical carcinoma cells to apoptotic stimuli (DeFeo-Jones et al.)
- Blocks mitosis and inhibits migration of HeLa cells (Jo et al.)
- Reduces insulin-dependent gene repression in liver cells leading to reduced insulin sensitivity (Logie et al.)
Specifications
612847-09-3 | |
AKTi-1/2; AKT 1/2 inhibitor | |
C34H29N7O | |
≥98% |